RxDoctor Payments Data

Raymond Hah, MD

Orthopaedic Surgery of the Spine · Los Angeles, CANPI 1881989762

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (49.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 80.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $326,329 and has fallen 57.5% since, to $138,805 in 2025. Among orthopaedic surgery of the spine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$860,493in general payments, 2019–2025

Across 602 payments — averaging $1429.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$692K
  • Medtronic$58K
  • Orthofix Medical, Inc.$45K
  • Spineart USA Inc$27K
  • Si-bone, Inc.$13K
  • Evolution Spine, LLC$10K
  • plus $16K from 16 others
$29,943in research payments, 2019–2025

Across 15 payments — averaging $1996.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Si-bone, Inc.$30K

What the payments were for

  • Royalty or licence$425,00049%
  • Consulting fees$314,91037%
  • Speaking & faculty fees$21,3402%
  • Travel & lodging$76,9649%
  • Food & beverage$22,2583%
  • Entertainment$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$860,493 in reported general payments places this provider in the 90th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$473,080
Medicare patients
561
Services billed
1,517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin137$1,476
Celecoxib13$665
Methocarbamol25$130
Methylprednisolone19$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →